Skip to content

Drug interactions

Erythromycin base + Nilotinib

Severity: Major

Erythromycin base and Nilotinib: major interaction.

Last updated Sources: UK SmPC

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Erythromycin inhibits CYP3A4 and raises nilotinib levels, while both drugs prolong the QT interval. Together this markedly increases the risk of torsades de pointes and sudden death.

What this interaction means in plain words

Erythromycin base and Nilotinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Evidence level: High

Why it happens

CYP3A4 inhibition raises nilotinib exposure, combined with additive QT prolongation.

What to do

Avoid and use a non-macrolide antibiotic such as one without CYP3A4 inhibition or QT effects. If unavoidable, reduce the nilotinib dose per labeling and monitor ECG and electrolytes.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Erythromycin base and Nilotinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

References

Frequently asked questions

Can I take Erythromycin base with Nilotinib?

MediHelp rates the interaction as major. Erythromycin base and Nilotinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Erythromycin inhibits CYP3A4 and raises nilotinib levels, while both drugs prolong the QT interval. Together this markedly increases the risk of torsades de pointes and sudden death.

How serious is the interaction between Erythromycin base and Nilotinib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid and use a non-macrolide antibiotic such as one without CYP3A4 inhibition or QT effects. If unavoidable, reduce the nilotinib dose per labeling and monitor ECG and electrolytes.

What other medicines interact with Nilotinib?

MediHelp also lists interactions of Nilotinib with, for example, Amiodarone, Arsenic trioxide, Disopyramide. The full list is on the Nilotinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in